107 related articles for article (PubMed ID: 38759113)
1. Distinct features of ANCA-associated hypertrophic pachymeningitis compared to other etiologies: findings from a study of 74 patients.
Martín-Nares E; Romero-Sánchez G; Cortez-Domínguez EU; Cano-Cruz LG; Hinojosa-Azaola A
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38759113
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.
Choi HA; Lee MJ; Chung CS
J Neurol; 2017 Apr; 264(4):724-732. PubMed ID: 28220286
[TBL] [Abstract][Full Text] [Related]
4. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic Pachymeningitis Development in Eosinophilic Granulomatosis with Polyangiitis at Relapse of Disease: A Case-Based Review.
Kiyohara M; Shirai T; Nishiyama S; Sato H; Fujii H; Ishii T; Harigae H
Tohoku J Exp Med; 2022 Mar; 256(3):241-247. PubMed ID: 35321968
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights.
Shimojima Y; Sekijima Y
Autoimmun Rev; 2023 Jun; 22(6):103338. PubMed ID: 37062439
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Shimojima Y; Kishida D; Hineno A; Yazaki M; Sekijima Y; Ikeda SI
Int J Rheum Dis; 2017 Apr; 20(4):489-496. PubMed ID: 28217942
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.
Xia C; Li P
Front Neurol; 2022; 13():986694. PubMed ID: 36188377
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
Shimojima Y; Kishida D; Ichikawa T; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Hirata S; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Sekijima Y
Arthritis Res Ther; 2022 Aug; 24(1):204. PubMed ID: 35999568
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of hypertrophic cranial pachymeningitis in granulomatosis with polyangiitis: a retrospective single-center study in China.
Chen Y; Gou L; Wang L; Qian M; Wu Q; Zheng W; Li M; Zeng X; Zhang F
Arthritis Res Ther; 2024 Jan; 26(1):6. PubMed ID: 38169421
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study.
Xiao X; Fu D; Feng L
Front Neurol; 2020; 11():565088. PubMed ID: 33281701
[No Abstract] [Full Text] [Related]
12. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
13. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA.
Wyrostek S; Chakrabarti S; Baldwin K; Avila JD
Case Rep Neurol; 2019; 11(3):290-294. PubMed ID: 31762760
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
Izuka S; Yamashita H; Takahashi Y; Kaneko H
Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
[TBL] [Abstract][Full Text] [Related]
15. [IgG4- and MPO-ANCA-associated hypertrophic pachymeningitis].
Aragonès JM; Arias-Rivero M; García-Barrionuevo JM; Lucchetti G
Rev Neurol; 2015 Nov; 61(10):454-7. PubMed ID: 26553176
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic Pachymeningitis: An Unusual Cause of Headache.
Enabi J; Sharif MW; Venkatesan R; Kondakindi H; Faheem M
Cureus; 2024 Feb; 16(2):e53576. PubMed ID: 38445136
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
19. IgG4-related disease and hypertrophic pachymeningitis.
Wallace ZS; Carruthers MN; Khosroshahi A; Carruthers R; Shinagare S; Stemmer-Rachamimov A; Deshpande V; Stone JH
Medicine (Baltimore); 2013 Jul; 92(4):206-216. PubMed ID: 23793110
[TBL] [Abstract][Full Text] [Related]
20. A nationwide survey of hypertrophic pachymeningitis in Japan.
Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
